Manipal Hospitals, one of India’s foremost integratedhealthcare providers, has adopted a leading Australian decision-support solution for theirradiology practice. Harrison.ai’s chest X-ray (CXR) and Reporting solutions are being used toimprove the efficiency, quality, and turnaround time of chest X-ray reporting, which is one ofthe preliminary and
The Indian Medical Association (IMA) has strongly condemned the arrest of a doctor in connection with the recent deaths allegedly linked to contaminated cough syrup in Madhya Pradesh, calling the move “unjustified” and “deeply demoralizing for the medical fraternity.”In a statement issued on Monday, the
Representation also sent to the Central Drugs Standard Control Organization Urgent appeal to ban nicotine pouches and gums – the next new-age gateway threat Licensed pharmaceutical companies used as a front to sell nicotine pouches in India MNC Tobacco Companies are allegedly commissioning research
· Beyfortus® (nirsevimab) is the first monoclonal antibody approved to protect all infants born during or entering their 1st Respiratory Syncytial Virus (RSV) season · Dr. Reddy’s receives exclusive rights from Sanofi to promote and distribute Beyfortus® in India · This announcement follows Dr. Reddy’s successful exclusive distribution partnership with Sanofi for their
The Association of Indian Medical Device Industry (AiMeD) has raised strong objections to a recent notification issued on March 10, 2025, by the Commissionerate of Health, Medical Services & Medical Education, Government of Gujarat. The notification sets an unjust reimbursement structure, allocating ₹25,000 for USFDA-approved
Adults taking Mounjaro® with diet and exercise in a controlled clinical trial lost on average 21.8 kg. at the highest dose (15mg) and 15.4 kg at the lowest dose (5mg)over a period of 72 weeks.1,2 Individual results may varyMounjaro® delivered superior A1C reductions
Since July 2023 only 14 serious international complaints received , being future ready for coming winter season more than 8000 batches of cough syrup tested and only 2-3 per cent failures found The Central Drugs Standard Control Organization (CDSCO) announced a low failure rate of just
